Nanodropper's FDA-Listed Adaptor Targets 80% Eyedrop Waste With Volume-Reducing Design
SHERIDAN, WYOMING - April 14, 2026 - Nanodropper has developed the only FDA-listed, volume-reducing adaptor for commercial eyedrop bottles, targeting a structural inefficiency in ophthalmic drug delivery that decades of clinical research have identified but pharmaceutical packaging has not resolved. The device attaches by twisting onto a compatible bottle and reduces dispensed drop volume by more than 60%. Standard eyedrop bottles produce drops approximately five times larger than the eye can absorb, causing up to 80% of each dose to be lost through facial overflow or tear duct drainage into systemic circulation. Clinical evidence indicates smaller drops deliver equivalent therapeutic effect while reducing systemic absorption and associated side effects.